STXS — Stereotaxis, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1289340 ·
Last close
$1.42
Market Cap
$142.29M
52W High
$2.10
52W Low
$1.24
ADV30
1,132,450
Next earnings
2026-11-16
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 6,291,000 | 3,794,000 | -5,981,000 | -5,861,000 | 54,030,000 | 14,616,000 | 34,432,000 |
| Dec 2025 | 8,642,000 | 4,327,000 | -5,649,000 | -5,531,000 | 52,251,000 | 13,421,000 | 33,530,000 |
| Sep 2025 | 7,464,000 | 4,101,000 | -6,557,000 | -6,463,000 | 45,587,000 | 10,506,000 | 34,053,000 |
| Jun 2025 | 8,798,000 | 4,579,000 | -3,977,000 | -3,826,000 | 41,173,000 | 6,967,000 | 34,421,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,348,000
Investing CF
$-172,000
Financing CF
$19,447,000
CapEx
$-151,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.24
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-589,229,000
Inventory
$10,495,000
Receivables
$9,619,000
ST Investments
—
EBIT TTM
$-22,164,000
Pretax Income TTM
$-21,681,000
Interest Exp TTM
—
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$30,068,000
EBITDA
$-18,058,000
Free Cash Flow
$-8,830,500
Enterprise Value
$142,203,088
Total Cash
$10,491,000
Total Debt
$5,173,000
Shares Out
100,202,178
Trailing EPS
$-0.24
Book Value
$0.12
ROE
-184.3%
ROA
-25.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 32,377,000 | -22,112,000 | -21,643,000 | 52,251,000 | 33,530,000 | — | -13,685,000 |
| Dec 2024 | 26,918,000 | -24,739,000 | -24,045,000 | 46,724,000 | 35,292,000 | — | -8,497,000 |
| Dec 2023 | 26,771,000 | -21,839,000 | -20,713,000 | 41,909,000 | 19,989,000 | — | -9,139,000 |
| Dec 2022 | 28,147,000 | -18,776,000 | -18,292,000 | 53,413,000 | 21,484,000 | — | -8,415,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.15
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.42 · call volume: 12 · put volume: 76
Expected Move to 2027-02-19:
±$1.31
(92.25%) —
implied range
$0.11 –
$2.73
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| INGN | Inogen Inc | $145.96M | $5.50 | — |
| KRMD | KORU Medical Systems, Inc. | $148.67M | $3.22 | — |
| APYX | Apyx Medical Corp | $129.74M | $3.08 | — |
| EBRCZ | EBR Systems, Inc. | $158.20M | $0.21 | — |
| NYXH | Nyxoah SA | $162.12M | $1.62 | — |
News headlines (Yahoo Finance, 1h cache)
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript
2026-08-18 22:44 · Yahoo
Stereotaxis Q2 Earnings Call Highlights
2026-08-12 03:04 · Yahoo
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
2026-08-11 21:45 · Yahoo
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates
2026-08-11 20:01 · Yahoo
Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026
2026-07-21 13:00 · Yahoo
Stereotaxis closes Robocath takeover
2026-07-09 17:00 · Yahoo
Stereotaxis Completes Acquisition of Robocath
2026-07-09 12:08 · Yahoo
University of Szeged Pioneers First Robotic Cardiology Program in Hungary
2026-07-20 12:31 · Yahoo
ISRG's US Procedure Growth Slows: Is ACA Headwind a Temporary Concern?
2026-08-12 18:33 · Yahoo
Stereotaxis, Inc. Q2 2026 Earnings Call Summary
2026-08-12 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.